These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12243835)

  • 21. Reduction of intimal hyperplasia with Re-188-labeled stents in a rabbit model at 7 and 26 weeks: an experimental study.
    Tepe G; Dietrich T; Grafen F; Brehme U; Muschick P; Dinkelborg LM; Greschniok A; Claussen CD; Duda SH
    Cardiovasc Intervent Radiol; 2005; 28(5):632-7. PubMed ID: 16059762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of neointimal formation after stent placement with adenovirus-mediated gene transfer of I kappa B alpha in the hypercholesterolemic rabbit model: initial results.
    Cejna M; Breuss JM; Bergmeister H; de Martin R; Xu Z; Grgurin M; Losert U; Plenk H; Binder BR; Lammer J
    Radiology; 2002 Jun; 223(3):702-8. PubMed ID: 12034938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra-arterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model.
    Verin V; Popowski Y; Urban P; Belenger J; Redard M; Costa M; Widmer MC; Rouzaud M; Nouet P; Grob E
    Circulation; 1995 Oct; 92(8):2284-90. PubMed ID: 7554213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of neointimal proliferation with 188Re-labeled self-expanding nitinol stent in a sheep model.
    Meyer JM; Nowak B; Schuermann K; Buecker A; Moltzahn F; Kulisch A; Heussen N; Görgen T; Büll U; Günther RW
    Radiology; 2003 Dec; 229(3):847-54. PubMed ID: 14657319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stent-induced intimal hyperplasia: are there fundamental differences between flexible and rigid stent designs?
    Fontaine AB; Spigos DG; Eaton G; Das Passos S; Christoforidis G; Khabiri H; Jung S
    J Vasc Interv Radiol; 1994; 5(5):739-44. PubMed ID: 8000123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muraglitazar-eluting bioabsorbable vascular stent inhibits neointimal hyperplasia in porcine iliac arteries.
    Uurto I; Hämäläinen M; Suominen V; Laurila M; Kotsar A; Isotalo T; Tammela TL; Kellomäki M; Salenius JP
    J Vasc Interv Radiol; 2015 Jan; 26(1):124-30. PubMed ID: 25454655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of endovascular radiation from a beta-particle-emitting stent in a porcine coronary restenosis model. A dose-response study.
    Carter AJ; Laird JR; Bailey LR; Hoopes TG; Farb A; Fischell DR; Fischell RE; Fischell TA; Virmani R
    Circulation; 1996 Nov; 94(10):2364-8. PubMed ID: 8921774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 90-day coronary vascular response to (90)Y-beta particle-emitting stents in the canine model.
    Taylor AJ; Gorman PD; Hudak C; Tashko G; Sweet W; Farb A; Virmani R
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):1019-24. PubMed ID: 10705025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A chemically modified dextran inhibits smooth muscle cell growth in vitro and intimal in stent hyperplasia in vivo.
    Deux JF; Prigent-Richard S; d'Angelo G; Feldman LJ; Puvion E; Logeart-Avramoglou D; Pellé A; Boudghène FP; Michel JB; Letourneur D
    J Vasc Surg; 2002 May; 35(5):973-81. PubMed ID: 12021714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis of restenosis with (186)re-labeled stents in a rabbit model.
    Tepe G; Dinkelborg LM; Brehme U; Muschick P; Noll B; Dietrich T; Greschniok A; Baumbach A; Claussen CD; Duda SH
    Circulation; 2001 Jul; 104(4):480-5. PubMed ID: 11468213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries.
    Waksman R; Pakala R; Baffour R; Seabron R; Hellinga D; Chan R; Su SH; Kolodgie F; Virmani R
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):429-36. PubMed ID: 22105925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new polymer concept for coating of vascular stents using PTFEP (poly(bis(trifluoroethoxy)phosphazene) to reduce thrombogenicity and late in-stent stenosis.
    Richter GM; Stampfl U; Stampfl S; Rehnitz C; Holler S; Schnabel P; Grunze M
    Invest Radiol; 2005 Apr; 40(4):210-8. PubMed ID: 15770139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local arterial responses to 32P beta-emitting stents.
    John M; Shroff S; Farb A; Virmani R
    Cardiovasc Radiat Med; 2001; 2(3):143-50. PubMed ID: 11786320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Edge Effect" of (32)p radioactive stents is caused by the combination of chronic stent injury and radioactive dose falloff.
    van Der Giessen WJ; Regar E; Harteveld MS; Coen VL; Bhagwandien R; Au A; Levendag PC; Ligthart J; Serruys PW; den Boer A; Verdouw PD; Boersma E; Hu T; van Beusekom HM
    Circulation; 2001 Oct; 104(18):2236-41. PubMed ID: 11684637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endovascular irradiation from beta-particle-emitting gold stents results in increased neointima formation in a porcine restenosis model.
    Schulz C; Niederer C; Andres C; Herrmann RA; Lin X; Henkelmann R; Panzer W; Herrmann C; Regulla DF; Wolf I; Ulm K; Alt E
    Circulation; 2000 Apr; 101(16):1970-5. PubMed ID: 10779464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term coronary vascular response to (32)P beta-particle-emitting stents in a canine model.
    Taylor AJ; Gorman PD; Farb A; Hoopes TG; Virmani R
    Circulation; 1999 Dec; 100(23):2366-72. PubMed ID: 10587342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The beta-particle-emitting radioisotope stent (isostent): animal studies and planned clinical trials.
    Fischell TA; Carter AJ; Laird JR
    Am J Cardiol; 1996 Aug; 78(3A):45-50. PubMed ID: 8751847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-dilatation intravascular brachytherapy trials on hypercholesterolemic rabbits using 32P-phosphate solutions in angioplasty balloons.
    Walichiewicz P; Wilczek K; Petelenz B; Jacheć W; Jochem J; Tomasik A; Bilski P; Gaca P; Banaszczuk J; Ihnatowicz J; Wodniecki J
    Cardiovasc Intervent Radiol; 2004; 27(1):42-50. PubMed ID: 15109228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits.
    Danenberg HD; Golomb G; Groothuis A; Gao J; Epstein H; Swaminathan RV; Seifert P; Edelman ER
    Circulation; 2003 Dec; 108(22):2798-804. PubMed ID: 14610008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral mycophenolate mofetil prevents in-stent intimal hyperplasia without edge effect.
    Ilkay E; Tirikli L; Ozercan I; Yavuzkir M; Karaca I; Rahman A; Arslan N
    Angiology; 2006; 57(5):577-84. PubMed ID: 17067980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.